艾滋病毒-1蛋白酶的过早激活受部区域的多形态的影响
Caroline O Tabler1, Sarah J Wegman1, Najwa Alhusaini1
1Center for Proteomics and Bioinformatics, Department of Nutrition, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Viruses
|June 27, 2024
概括
促进HIV-1蛋白酶激活可能提供一种新的疗法,但耐药性突变和多态性构成挑战. 了解病毒异质性是未来针对蛋白酶激活的治疗策略的关键.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药物发现 药物发现 药物发现
背景情况:
- 艾滋病毒-1蛋白酶抑制剂对于抗逆转录病毒疗法至关重要,但耐药性需要新的治疗方法.
- 新兴研究表明,激活宿主细胞内的HIV-1蛋白酶可以触发热,导致感染细胞死亡.
- 这为治疗策略开辟了道路,重点是促进HIV-1根除的蛋白酶激活.
研究的目的:
- 通过纳米级流细胞计测试来表征HIV-1蛋白酶耐药性突变和多态性.
- 量化蛋白酶活性,病毒载量和过早的蛋白酶激活.
- 研究耐药性突变和多态性对蛋白酶激活和稳定性的影响.
主要方法:
- 基于纳米级流细胞计的测定.
- 量化蛋白酶活性,病毒度和过早的蛋白酶激活.
- 描述HIV-1蛋白酶耐药性突变和多态性.
主要成果:
- 证实主要的HIV-1蛋白酶耐药性突变通常会破坏蛋白酶结构的稳定性.
- 发现蛋白酶链域中常见的多态性影响了对过早激活的易感性.
- 有证据表明,病毒异质性会影响蛋白酶激活.
结论:
- 虽然促进蛋白酶激活是治愈HIV-1的有希望的策略,但耐药性突变构成了挑战.
- 病毒的多态性,特别是在链领域,可以影响过早的蛋白酶激活.
- 未来的治疗策略必须考虑到病毒异质性,以有效诱导蛋白酶激活.
更多相关视频
10:50Assessment of Immunologically Relevant Dynamic Tertiary Structural Features of the HIV-1 V3 Loop Crown R2 Sequence by ab initio Folding
Published on: September 15, 2010
9.6K
07:10Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
14.3K
相关概念视频
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Viral Mutations
32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
